Euderruh Uzcátegui

576 total citations
13 papers, 475 citations indexed

About

Euderruh Uzcátegui is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Euderruh Uzcátegui has authored 13 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Euderruh Uzcátegui's work include Schizophrenia research and treatment (5 papers), Diet and metabolism studies (4 papers) and Pharmacology and Obesity Treatment (3 papers). Euderruh Uzcátegui is often cited by papers focused on Schizophrenia research and treatment (5 papers), Diet and metabolism studies (4 papers) and Pharmacology and Obesity Treatment (3 papers). Euderruh Uzcátegui collaborates with scholars based in Venezuela, Bolivia and Canada. Euderruh Uzcátegui's co-authors include Trino Baptista, Serge Beaulieu, Enma Araujo de Baptista, Nairy Rangel, Ana Serrano, Edgardo Carrizo, Salvador Navarro, E. Astudillo, Virginia Fernández and A. Sáenz and has published in prestigious journals such as Psychiatry Research, Schizophrenia Research and Drug and Alcohol Dependence.

In The Last Decade

Euderruh Uzcátegui

13 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Euderruh Uzcátegui Venezuela 11 288 173 166 75 65 13 475
Maria Teresa Cruz Lourenço Canada 12 177 0.6× 152 0.9× 86 0.5× 21 0.3× 59 0.9× 19 552
Chathurie Suraweera Sri Lanka 9 308 1.1× 147 0.8× 116 0.7× 34 0.5× 83 1.3× 26 581
Youssef Kouidrat France 10 308 1.1× 92 0.5× 236 1.4× 48 0.6× 40 0.6× 15 579
John Pendlebury United Kingdom 12 318 1.1× 121 0.7× 116 0.7× 62 0.8× 19 0.3× 16 505
Vicki Poole Hoffmann United States 16 382 1.3× 192 1.1× 120 0.7× 14 0.2× 64 1.0× 28 547
Keith Szymanski United States 7 200 0.7× 127 0.7× 77 0.5× 30 0.4× 46 0.7× 11 352
Madhubhashinee Dayabandara Sri Lanka 7 249 0.9× 142 0.8× 119 0.7× 19 0.3× 80 1.2× 17 465
Valerie Powell Canada 10 217 0.8× 50 0.3× 40 0.2× 23 0.3× 41 0.6× 18 321
Clara Odilia Sailer Switzerland 15 68 0.2× 79 0.5× 192 1.2× 84 1.1× 61 0.9× 37 663
Paul S. Mueller United States 7 61 0.2× 106 0.6× 61 0.4× 73 1.0× 81 1.2× 16 412

Countries citing papers authored by Euderruh Uzcátegui

Since Specialization
Citations

This map shows the geographic impact of Euderruh Uzcátegui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euderruh Uzcátegui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euderruh Uzcátegui more than expected).

Fields of papers citing papers by Euderruh Uzcátegui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Euderruh Uzcátegui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euderruh Uzcátegui. The network helps show where Euderruh Uzcátegui may publish in the future.

Co-authorship network of co-authors of Euderruh Uzcátegui

This figure shows the co-authorship network connecting the top 25 collaborators of Euderruh Uzcátegui. A scholar is included among the top collaborators of Euderruh Uzcátegui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Euderruh Uzcátegui. Euderruh Uzcátegui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Uzcátegui, Euderruh, et al.. (2015). Prevalence of the metabolic syndrome, insulin resistance index, leptin and thyroid hormone levels in the general population of Merida (Venezuela).. PubMed. 56(2). 169–81. 6 indexed citations
2.
3.
Serrano, Ana, et al.. (2013). Safety of long-term clozapine administration. Frequency of cardiomyopathy and hyponatraemia: Two cross-sectional, naturalistic studies. Australian & New Zealand Journal of Psychiatry. 48(2). 183–192. 13 indexed citations
4.
Serrano, Ana, et al.. (2012). Olanzapine as an add-on treatment in migraine status: A randomized double-blind, placebo-controlled, pilot study. The European Journal of Psychiatry. 26(4). 260–265. 1 indexed citations
5.
Baptista, Trino, et al.. (2012). Migraine life-time prevalence in mental disorders: concurrent comparisons with first-degree relatives and the general population.. PubMed. 53(1). 38–51. 16 indexed citations
6.
7.
8.
9.
Baptista, Trino, et al.. (2008). Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain. CNS Drugs. 22(6). 477–495. 88 indexed citations
10.
Baptista, Trino, Nairy Rangel, Virginia Fernández, et al.. (2007). Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial. Schizophrenia Research. 93(1-3). 99–108. 112 indexed citations
11.
Baptista, Trino, Euderruh Uzcátegui, Nairy Rangel, et al.. (2007). Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia. International Clinical Psychopharmacology. 22(4). 205–211. 38 indexed citations
12.
Fernández‐Cruz, Laureano, A. Sáenz, E. Astudillo, et al.. (2002). Laparoscopic pancreatic surgery in patients with chronic pancreatitis. Surgical Endoscopy. 16(6). 996–1003. 56 indexed citations
13.
Baptista, Trino & Euderruh Uzcátegui. (1993). Substance use among resident doctors in Venezuela. Drug and Alcohol Dependence. 32(2). 127–132. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Teresa Cruz Lourenço Breakdown of academic impact, for papers by Chathurie Suraweera Breakdown of academic impact, for papers by Youssef Kouidrat Breakdown of academic impact, for papers by John Pendlebury Breakdown of academic impact, for papers by Vicki Poole Hoffmann Breakdown of academic impact, for papers by Keith Szymanski Breakdown of academic impact, for papers by Madhubhashinee Dayabandara Breakdown of academic impact, for papers by Valerie Powell Breakdown of academic impact, for papers by Clara Odilia Sailer Breakdown of academic impact, for papers by Paul S. Mueller
Rankless by CCL
2026